Christine Fox, EVP, Head of U.S. Commercial: Teva Pharmaceutical Industries TEVA Sell · Filed 24/11/21

Trade details

Type: Insider sale
Amount: $327,075.56
Shares · price: 19,388 sh · $16.87 a share
Held after: 44,104 sh
Stock: Teva Pharmaceutical Industries TEVA
Person: Christine FoxEVP, Head of U.S. Commercial
Trade date: 24/11/20
Filed: 24/11/21
Days to filing: 1 days

Sold 30.5% of holdings

Share of holding sold: 30.5%

Teva Pharmaceutical Industries trades, last 26 weeks

What else happened in Teva Pharmaceutical Industries around then

Filed or reported within 30 days of the trade day · 24/10/21~24/12/20

Christine Fox's recent trades

Christine FoxEVP, U.S. Commercial
SellTeva Pharmaceutical Industries
Sell
Teva Pharmaceutical Industries
TEVA
$750.6K
21,258 sh
$750.6K
Filed 05/04
Traded 04/30
Christine FoxEVP, U.S. Commercial
Planned saleTeva Pharmaceutical Industries
Planned sale
Teva Pharmaceutical Industries
TEVA
$750.6K
21,258 sh
$750.6K
Filed 04/30
Traded 04/30
Christine FoxEVP, U.S. Commercial
Sell10b5-1 planTeva Pharmaceutical Industries
Sell10b5-1 plan
Teva Pharmaceutical Industries
TEVA
$251K
7,924 sh
$251K
Filed 03/09
Traded 03/05
Christine FoxEVP, U.S. Commercial
Sell10b5-1 planTeva Pharmaceutical Industries
Sell10b5-1 plan
Teva Pharmaceutical Industries
TEVA
$295.3K
9,098 sh
$295.3K
Filed 03/06
Traded 03/04
Christine FoxEVP, U.S. Commercial
Planned sale10b5-1 planTeva Pharmaceutical Industries
Planned sale10b5-1 plan
Teva Pharmaceutical Industries
TEVA
$250.9K
7,924 sh
$250.9K
Filed 03/05
Traded 03/05